Regular drug-eluting stents versus dedicated bifurcation drug-eluting BiOSS stents for coronary bifurcation treatment: four-year results of the randomised POLBOS I and POLBOS II clinical trials

EuroIntervention. 2020 Mar 20;15(16):1460-1463. doi: 10.4244/EIJ-D-18-00172.

Authors

Robert J Gil¹, Jacek Bil, Adam Kern, Luis A Ingio Garcia, Radoslaw Formuszewicz, Slawomir Dobrzycki, Dobrin Vassilev, Agnieszka Segiet

Affiliation

¹ Department of Invasive Cardiology, Centre of Postgraduate Medical Education, Central Clinical Hospital of the Ministry of Interior and Administration, Warsaw, Poland.

PMID: 29741487
DOI: 10.4244/EIJ-D-18-00172

No abstract available

Publication types

Randomized Controlled Trial

MeSH terms

Coronary Stenosis* / surgery
Drug-Eluting Stents*
Humans
Sirolimus
Treatment Outcome

Substances

Sirolimus